Neon Therapeutics (NTGN) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free NTGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Neon Therapeutics Short Interest DataCurrent Short Volume743,900 sharesPrevious Short Volume644,800 sharesChange Vs. Previous Month+15.37%Dollar Volume Sold Short$2.24 millionShort Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2020Outstanding Shares28,967,000 sharesFloat Size15,200,000 sharesShort Percent of Float4.89%Today's Trading Volume0 sharesAverage Trading Volume516,108 sharesToday's Volume Vs. Average0% Short Selling Neon Therapeutics ? Sign up to receive the latest short interest report for Neon Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNTGN Short Interest Over TimeNTGN Days to Cover Over TimeNTGN Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Neon Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2020743,900 shares $2.24 million +15.4%4.9%1.7 $3.01 4/15/2020743,900 shares $1.65 million +15.4%4.9%1.7 $2.22 3/31/2020644,800 shares $1.70 million +8.0%4.2%1.3 $2.64 3/13/2020597,000 shares $871,620.00 -23.5%4.4%1.9 $1.46 2/28/2020780,500 shares $1.17 million +2.2%5.7%2.1 $1.50 2/14/2020763,700 shares $1.11 million +19.3%5.4%2 $1.45 1/31/2020640,300 shares $864,405.00 +3.0%4.6%1.7 $1.35 1/15/2020621,800 shares $758,596.00 +8.4%4.5%1.8 $1.22 12/31/2019573,900 shares $677,202.00 -19.6%4.0%2.8 $1.18 8/15/2019600,600 shares $1.68 million +5.4%4.4%3.3 $2.79 NTGN Short Interest - Frequently Asked Questions What is Neon Therapeutics' current short interest? Short interest is the volume of Neon Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 743,900 shares of NTGN short. 4.89% of Neon Therapeutics' shares are currently sold short. Learn More on Neon Therapeutics' current short interest. What is a good short interest ratio for Neon Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NTGN shares currently have a short interest ratio of 2.0. Learn More on Neon Therapeutics's short interest ratio. What is a good short interest percentage for Neon Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.89% of Neon Therapeutics' floating shares are currently sold short. Is Neon Therapeutics' short interest increasing or decreasing? Neon Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 743,900 shares, an increase of 15.4% from the previous total of 644,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Neon Therapeutics' float size? Neon Therapeutics currently has issued a total of 28,967,000 shares. Some of Neon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neon Therapeutics currently has a public float of 15,200,000 shares. How does Neon Therapeutics' short interest compare to its competitors? 4.89% of Neon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Neon Therapeutics: Curis, Inc. (1.01%), AlloVir, Inc. (5.57%), Atara Biotherapeutics, Inc. (9.59%), Sangamo Therapeutics, Inc. (6.39%), Vigil Neuroscience, Inc. (6.18%), Athira Pharma, Inc. (2.94%), Cognition Therapeutics, Inc. (0.73%), Passage Bio, Inc. (4.24%), Gritstone bio, Inc. (13.16%), bluebird bio, Inc. (29.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($7.01 billion), Charter Communications, Inc. ($4.31 billion), Match Group, Inc. ($2.95 billion), The Charles Schwab Co. ($2.81 billion), Tesla, Inc. ($2.69 billion), Microchip Technology Incorporated ($2.59 billion), Wayfair Inc. ($2.19 billion), Snap Inc. ($1.99 billion), The Clorox Company ($1.97 billion), and International Flavors & Fragrances Inc. ($1.92 billion). View all of the most shorted stocks. What does it mean to sell short Neon Therapeutics stock? Short selling NTGN is an investing strategy that aims to generate trading profit from Neon Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neon Therapeutics? A short squeeze for Neon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NTGN, which in turn drives the price of the stock up even further. How often is Neon Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NTGN, twice per month. The most recent reporting period available is April, 30 2020. More Short Interest Resources from MarketBeat Related Companies: CRIS Short Interest ALVR Short Interest ATRA Short Interest SGMO Short Interest VIGL Short Interest ATHA Short Interest CGTX Short Interest PASG Short Interest GRTS Short Interest BLUE Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NTGN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets